Inhaled Budesonide for Altitude Illness Prevention
Status:
Withdrawn
Trial end date:
2017-03-06
Target enrollment:
Participant gender:
Summary
A randomized, double-blinded study administering budesonide, a medication to reduce
inflammation in the lungs, to healthy volunteers to examine effects on altitude illness
prevention by spending 18 hours overnight at 14,000 ft elevation.